Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Blanche H. Mavromatis"'
Autor:
Toni K. Choueiri, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L. Schmidt, Gilberto de Lima Lopes, Jr., Clara Hwang, Sunny R.K. Singh, Chinmay Jani, Lisa B. Weissmann, Elizabeth A. Griffiths, Susan Halabi, Ulysses Wu, Stephanie Berg, Timothy E. O'Connor, Trisha M. Wise-Draper, Orestis A. Panagiotou, Elizabeth J. Klein, Monika Joshi, Fares Yared, Miriam Santos Dutra, Na Tosha N. Gatson, Sibel Blau, Harpreet Singh, Rahul Nanchal, Rana R. McKay, Taylor K. Nonato, Ryann Quinn, Samuel M. Rubinstein, Matthew Puc, Blanche H. Mavromatis, Praveen Vikas, Bryan Faller, Howard A. Zaren, Salvatore Del Prete, Karen Russell, Daniel Y. Reuben, Melissa K. Accordino, Christopher R. Friese, Sanjay Mishra, Donna R. Rivera, Yu Shyr, Dimitrios Farmakiotis, Jeremy L. Warner
Publikováno v:
The Lancet Regional Health. Americas, Vol 19, Iss , Pp 100445- (2023)
Summary: Background: Breakthrough SARS-CoV-2 infections following vaccination against COVID-19 are of international concern. Patients with cancer have been observed to have worse outcomes associated with COVID-19 during the pandemic. We sought to eva
Externí odkaz:
https://doaj.org/article/e370428645e4460e9f6ede1b1e0c1c34
Autor:
Toni K. Choueiri, Chris Labaki, Ziad Bakouny, Chih-Yuan Hsu, Andrew L. Schmidt, Gilberto de Lima Lopes, Clara Hwang, Sunny R.K. Singh, Chinmay Jani, Lisa B. Weissmann, Elizabeth A. Griffiths, Susan Halabi, Ulysses Wu, Stephanie Berg, Timothy E. O’Connor, Trisha M. Wise-Draper, Orestis A. Panagiotou, Elizabeth J. Klein, Monika Joshi, Miriam Santos Dutra, Na Tosha N. Gatson, Sibel Blau, Harpreet Singh, Rahul Nanchal, Rana R. McKay, Taylor K. Nonato, Ryann Quinn, Samuel M. Rubinstein, Matthew Puc, Blanche H. Mavromatis, Praveen Vikas, Bryan Faller, Howard A. Zaren, Salvatore Del Prete, Karen Russell, Daniel Y. Reuben, Melissa Accordino, Christopher R. Friese, Sanjay Mishra, Donna R. Rivera, Yu Shyr, Dimitrios Farmakiotis, Jeremy L. Warner
Publikováno v:
SSRN Electronic Journal.
Autor:
Bruce D. Cheson, Blanche H. Mavromatis
Publikováno v:
Blood Reviews. 18:137-148
New therapies for chronic lymphocytic leukemia (CLL) are moving away from non-specific cytotoxic to more targeted approaches. The monoclonal antibody alemtuzumab induces responses in 33% to 43% of patients with relapsed or refractory disease, with 2-
Publikováno v:
JCR: Journal of Clinical Rheumatology. 4:147-150
Publikováno v:
Blood. 108:4856-4856
Background: Arsenic trioxide(As2O3) has proven clinical efficacy in relapsed acute promyelocytic leukemia, and is currently being studied in the upfront setting. At micromolar doses, As2O3 induces apoptosis and cellular differentiation, promotes hist
Autor:
Christopher E. Attinger, Bruce D. Cheson, Katherine Picken, Elizabeth M. Gaughan, Kara Couch, Craig M. Kessler, Thomas Cupps, Blanche H. Mavromatis
Publikováno v:
Blood. 108:4099-4099
Introduction: LUEs affect 6 million individuals annually in the US, with high morbidity and cost. Normal wound healing requires coagulation, inflammatory responses, angiogenesis, scar formation, and epithelialization. LUEs arise when any of these pat
Autor:
Bruce D. Cheson, Emre Zafer, Peter Acs, Metin Ozdemirly, Blanche H. Mavromatis, Jean Meck, Rebecca Slack, Daniel Hartmann
Publikováno v:
Blood. 106:2114-2114
Introduction. New prognostic markers such as ZAP-70, CD38, and cytogenetics have proven to be highly predictive of outcome in CLL. However, their role in the management and treatment of CLL patients (pts) has yet to be determined. Furthermore, the im
Publikováno v:
Blood. 106:5031-5031
CLL is usually an indolent lymphoproliferative disease; however pts are at risk over time (3-5% yr) of transformation to a more aggressive histology, e.g., prolymphocytic leukemia (PLL), or Richter’s transformation (RT). The outcome of these pts is
Autor:
Kanti R. Rai, Kenneth K. Chan, Blanche H. Mavromatis, Tracey Wei, Paul K. Wallace, Claudia Soho, Beverly Landrigan, Patricia Meyn, Steven Novick, Asher A. Chanan-Khan, Philomena Casey
Publikováno v:
Blood. 106:2129-2129
Bcl-2 is an anti-apoptotic protein closely linked to chemotherapy resistance and inferior survival in patients (pts) with CLL. Genasense (G) enhances apoptosis induced by fludarabine (F), dexamethasone, and rituximab (R) in vitro. Despite limited sin
Autor:
Metin Ozdemirli, Nicole D. Zantek, Blanche H. Mavromatis, Philip Cohen, Dan-Paul Hartmann, Bruce D. Cheson, Craig M. Kessler, Edmund A. Gehan
Publikováno v:
Blood. 104:4811-4811
ZAP-70 is a tyrosine kinase protein involved in T cell signaling, overexpression of which is associated with a poor prognosis in CLL. Clinical information on 32 pts with CLL, and 6 pts with prolymphocytic transformation (PLT) followed at our institut